MATERIALS AND METHODS
Peptide synthesis. The synthesis of the three protamine peptides ( Table 1) was performed on a microwave-assisted peptide synthesizer Liberty1 (CEM Corporation, Matthews, NC, USA) using N-fluorenylmethyloxycarbonyl (Fmoc) chemistry with O-Benzotriazole-N,N,N',N'-tetramethyl-uronium-hexafluoro-phosphate (HBTU) as activator. 1 For synthesis of phosphorylated peptides Fmoc-O-benzylphospho-L-serine monomer was used in order to get phosphorylated peptides without post-synthetic peptide modifications. The arginine residues were attached using double couplings with standard coupling conditions. The loading of Rink-amide MBHA resin was decreased down to 0.1 mmol/g in order to increase the efficiency of each coupling by reduction of steric effect.
The time of cleavage from the resin was increase up to 6 hours due to the high content of 2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl-protected (Pbf) arginine residues in the peptide sequences. As a result the yield of the synthesis was more than 90% calculated by resin growth after the synthesis and the crude purity was about ~50% according to preparative run HPLC profile (data not shown). After resin cleavage using a standard protocol 2 the crude peptide was purified using HPLC on a C12 reverse-phase column and the molecular weight of hPRM1 was confirmed by mass-spectrometry. In addition to mass-spectrometry analysis the acid-urea electrophoresis was performed as described to confirm MW of prepared peptides. 3 The purity of synthetic protamine and its analogs were analyzed by analytical HPLC and were more than 90% pure ( Figure S1 ).
The molecular weight of highly cationic peptides was also confirmed using acid-urea gel electrophoresis, which is based on differences in size and effective charge. This analysis was performed in comparison with Poly-L-Lysine (~280 kDa) and naturally occurring salmon protamine sulfate (~4.2 kDa), which have different sizes and charges. The band of synthetic h-PRM1 was between low MW protamine sulfate and high MW poly-LLysine (lane 3, Figure S2 ), which demonstrate the presence of our synthetic hPRM1 in the desired molecular weight range. The presence of disulfide bridges was verified by
Ellman's reagent (5,5'-dithiobis-(2-nitrobenzoic acid), which is widely used to detect free thiol groups in solution by measuring the absorbance of visible light at 412 nm. 4 Solution preparation. All peptide solutions were prepared at different concentrations (1-5 mg/ml) using phosphate-buffered solution (PBS) or ddH 2 O and pH was adjusted to physiological pH prior analysis. The solubility of peptides was sufficentlly good to produce 5 mg/ml solutions in order to obtain proper CEST contrast. Nucleotides were dissolved at 0.1-0.2 M concentrations in PBS and pH was adjusted as above.
Circular Dichroism (CD)
. CD spectra were collected at 25 °C on a Jasco J-715 spectropolarimeter. Ellipticity-dependent wavelength spectra of PS and peptide solutions were obtained in a 1 mm quartz cell. Mean residue ellipticity [θ] was calculated using ridge regression (CONTIN) 5 and self-consistent methods (SELCON3) 6 on DichroWeb software.
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Dynamic Light Scattering (DLS). Hydrodynamic mean diameter of the particles was determined by dynamic light scattering studies using a Zetasizer Nano-S apparatus (Malvern Instruments, United Kingdom). Peptide solutions were prepared in PBS and water. All results were based on three or four measurements from two independent samples. All data were converted to ''relative by intensity'' plots from where the mean hydrodynamic diameter was derived.
MRI. MR data of synthetic peptides at different pH values, concentrations and complexed with nucleotides or heparin solutions were acquired on an 11.7 T Bruker Avance system (Bruker Biosciences, Billerica, MA, USA) using a 20 mm birdcage transmit/receive coil and saturation pulses with B 1 = 1.2 µT, 2.4 µT, 3.6 µT, 4.7 µT, 5.9 µT, 7.2 µT and 10.8
µT, T sat = 4 s followed by a RARE readout (RARE=8, TR/TE=6000ms/19.09ms). The CEST contrast was calculated as MTR asym function:
Signal intensity data (S w ) were processed using Matlab and Prism 6 software. Table S1 . Average diameter (size, nm±SD) of PS and hPRM1 nanoparticles alone or complexed with AMP, 5'-ATP and heparin determined by DLS measurements at 25°C
and binding constants (Keq) of protamines with 5'-AMP, 5'-ATP and heparin.
Concentration of peptide solutions is 0.5 mg/ml. 
